Browse
We’re here to help

Find guidance on Author Services

Search
Browse
We’re here to help

Find guidance on Author Services

Home
All Journals
Expert Opinion on Investigational Drugs
List of Issues
Volume 21, Issue 12

Expert Opinion on Investigational Drugs

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Expert Opinion on Investigational Drugs, Volume 21, Issue 12 (2012)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Investigational Drugs, Volume 21, Issue 12 (2012)

See all volumes and issues

Vol 33, 2024 Vol 32, 2023 Vol 31, 2022 Vol 30, 2021 Vol 29, 2020 Vol 28, 2019 Vol 27, 2018 Vol 26, 2017 Vol 25, 2016 Vol 24, 2015 Vol 23, 2014 Vol 22, 2013 Volume 21, 2012 Vol 20, 2011 Vol 19, 2010 Vol 18, 2009 Vol 17, 2008 Vol 16, 2007 Vol 15, 2006 Vol 14, 2005 Vol 13, 2004 Vol 12, 2003 Vol 11, 2002 Vol 10, 2001 Vol 9, 2000 Vol 8, 1999 Vol 7, 1998 Vol 6, 1997 Vol 5, 1996 Vol 4, 1995 Vol 3, 1994

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Research Article

Article

Related articles

Page: 1

Published online: 09 Nov 2012

41 Views
0 CrossRef citations
0Altmetric

Editorial

The battle against ALK resistance: successes and setbacks

Claudia Voena & Roberto Chiarle

Pages: 1751-1754

Published online: 25 Aug 2012

AbstractforThe battle against ALK resistance: successes and setbacks | Full Text | References | PDF (166.1 KB)

1279 Views
15 CrossRef citations
0Altmetric

Free Access

Reviews

Review Article

JAK2 inhibitors in the treatment of myeloproliferative neoplasms

Raoul Tibes, James M Bogenberger, Holly L Geyer & Ruben A Mesa

Pages: 1755-1774

Published online: 19 Sep 2012

AbstractforJAK2 inhibitors in the treatment of myeloproliferative neoplasms | Full Text | References | PDF (293.9 KB)

425 Views
12 CrossRef citations
0Altmetric

Review Article

The promise of mTOR inhibitors in the treatment of colorectal cancer

Dae-Dong Kim MD & Cathy Eng MD FACP

Pages: 1775-1788

Published online: 16 Sep 2012

AbstractforThe promise of mTOR inhibitors in the treatment of colorectal cancer | Full Text | References | PDF (297.9 KB)

438 Views
22 CrossRef citations
0Altmetric

Review Article

Antimycobacterial drugs currently in Phase II clinical trials and preclinical phase for tuberculosis treatment

Jean Engohang-Ndong PhD

Pages: 1789-1800

Published online: 19 Sep 2012

AbstractforAntimycobacterial drugs currently in Phase II clinical trials and preclinical phase for tuberculosis treatment | Full Text | References | PDF (234.5 KB)

536 Views
28 CrossRef citations
0Altmetric

Review Article

Terpenoids: natural products for cancer therapy

Min Huang, Jin-Jian Lu, Ming-Qing Huang, Jiao-Lin Bao, Xiu-Ping Chen & Yi-Tao Wang

Pages: 1801-1818

Published online: 23 Oct 2012

AbstractforTerpenoids: natural products for cancer therapy | Full Text | References | PDF (980.5 KB)

1263 Views
214 CrossRef citations
0Altmetric

Review Article

mGluR antagonists and GABA agonists as novel pharmacological agents for the treatment of autism spectrum disorders

Lindsay M Oberman PhD

Pages: 1819-1825

Published online: 26 Sep 2012

AbstractformGluR antagonists and GABA agonists as novel pharmacological agents for the treatment of autism spectrum disorders | Full Text | References | PDF (190.4 KB)

718 Views
35 CrossRef citations
0Altmetric

Review Article

Noradrenergic reuptake inhibition in the treatment of pain

Craig T Hartrick MD

Pages: 1827-1834

Published online: 08 Oct 2012

AbstractforNoradrenergic reuptake inhibition in the treatment of pain | Full Text | References | PDF (202.9 KB)

360 Views
15 CrossRef citations
0Altmetric

Drug Evaluations

Article

Everolimus in the treatment of hormone receptor-positive breast cancer

Mariana Chavez-MacGregor MD MSc & Ana Maria Gonzalez-Angulo MD MSc

Pages: 1835-1843

Published online: 20 Sep 2012

Abstractfor Everolimus in the treatment of hormone receptor-positive breast cancer | Full Text | References | PDF (370.3 KB)

482 Views
10 CrossRef citations
0Altmetric

Article

Tetomilast: new promise for phosphodiesterase-4 inhibitors?

Stephen J Bickston MD AGAF, Kenneth R Snider PharmD BCPS & Matthew R Kappus MD

Pages: 1845-1849

Published online: 08 Oct 2012

AbstractforTetomilast: new promise for phosphodiesterase-4 inhibitors? | Full Text | References | PDF (226.4 KB)

528 Views
14 CrossRef citations
0Altmetric

Article

Tivozanib: current status and future directions in the treatment of solid tumors

Sumanta K Pal MD, Paulo G Bergerot MD & Robert A Figlin MD

Pages: 1851-1859

Published online: 26 Sep 2012

Abstractfor Tivozanib: current status and future directions in the treatment of solid tumors | Full Text | References | PDF (397 KB)

328 Views
11 CrossRef citations
0Altmetric

Article

Glutamine as a supplemental treatment in pediatric and adult oncology patients

Teresa Stachowicz-Stencel MD PhD & Anna Synakiewicz MD

Pages: 1861-1871

Published online: 23 Aug 2012

AbstractforGlutamine as a supplemental treatment in pediatric and adult oncology patients | Full Text | References | PDF (204.3 KB)

463 Views
7 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

The role of extracellular vesicles in immune cell exhaustion and resistance to immunotherapy

Ava Aghakhani et al.

Review Article | Published online: 30 May 2024

Plain Language Summary of the PAISLEY study: deucravacitinib as a treatment for people with systemic lupus erythematosus

Eric F. Morand et al.

Plain Language Summary of Publication | Published online: 29 May 2024

Open Access

Inflammation and Huntington’s disease – a neglected therapeutic target?

Sophie E. Field et al.

Review Article | Published online: 29 May 2024

Open Access

Clinical application and potential pluripotent effects of hepatocyte growth factor in spinal cord injury regeneration

Shogo Hashimoto et al.

Review Article | Published online: 29 May 2024

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Investigational Drugs (Vol.21, Iss.12, 2012)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?